Completed Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn) NCT06599749 Conditions Adenocarcinoma, Adenocarcinoma of Ovary, Adenocarcinoma, Tubular, +9 more Locations University Hospital Basel — Basel, Switzerland Kantonsspital Baselland — Liestal, Switzerland University Hospital Zurich — Zurich, Switzerland View Trial Details
Active, Not Recruiting A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. NCT05335993 Conditions Adenocarcinoma of Ovary, Adnexal Diseases, Carcinoma, +25 more Locations Duke Cancer Center — Durham, North Carolina, United States Stephenson Cancer Center- University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States University of Virginia Health System — Charlottesville, Virginia, United States View Trial Details
